170 related articles for article (PubMed ID: 28406702)
1. An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery.
Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Trachta P; Kosák M; Krátký J; Kasalický M; DoleŽalová K; Mráz M; Haluzík M
Physiol Res; 2017 Sep; 66(4):641-652. PubMed ID: 28406702
[TBL] [Abstract][Full Text] [Related]
2. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.
Grannes H; Ueland T; Simeone P; Liani R; Guagnano MT; Aukrust P; Michelsen AE; Birkeland K; di Castelnuovo A; Cipollone F; Consoli A; Halvorsen B; Gregersen I; Santilli F
Cardiovasc Diabetol; 2024 Apr; 23(1):146. PubMed ID: 38685051
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
[TBL] [Abstract][Full Text] [Related]
8. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass.
Fjeldborg K; Pedersen SB; Møller HJ; Rask P; Danielsen AV; Stødkilde-Jørgensen H; Richelsen B
Obesity (Silver Spring); 2015 Jan; 23(1):154-61. PubMed ID: 25376508
[TBL] [Abstract][Full Text] [Related]
10. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
11. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation.
Cinkajzlova A; Lacinova Z; Klouckova J; Kavalkova P; Trachta P; Kosak M; Haluzikova D; Papezova H; Mraz M; Haluzík M
Endocr Res; 2017 Feb; 42(1):22-30. PubMed ID: 27135654
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
Tanimura H; Mizuno K; Okamoto H
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
[TBL] [Abstract][Full Text] [Related]
14. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
Davis BH; Zarev PV
Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus.
Hattori A; Takemoto M; Tokuyama H; Koshizaka M; Yokote K
Diabetes Res Clin Pract; 2017 Apr; 126():138-143. PubMed ID: 28237860
[TBL] [Abstract][Full Text] [Related]
16. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
[TBL] [Abstract][Full Text] [Related]
17. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
[TBL] [Abstract][Full Text] [Related]
19. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
